Biotalys NV (EBR: BTLS)
Belgium
· Delayed Price · Currency is EUR 2.970
-0.020 (-0.67%)
Nov 18, 2024, 3:29 PM CET
Biotalys NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | - | - | - | - | - | 5.89 | Upgrade
|
| Revenue | - | - | - | - | - | 5.89 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 91.20% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 7.34 | Upgrade
|
| Gross Profit | - | - | - | - | - | -1.45 | Upgrade
|
| Selling, General & Admin | 6.27 | 6.89 | 6.67 | 5.69 | 3.19 | 2.39 | Upgrade
|
| Research & Development | 13.08 | 16.61 | 18.81 | 13.88 | 11.49 | - | Upgrade
|
| Other Operating Expenses | -2.75 | -2.61 | -2.95 | -2 | -1.4 | -0.54 | Upgrade
|
| Operating Expenses | 16.61 | 20.89 | 22.53 | 17.58 | 13.28 | 8.12 | Upgrade
|
| Operating Income | -16.61 | -20.89 | -22.53 | -17.58 | -13.28 | -9.57 | Upgrade
|
| Interest Expense | -0.13 | -0.16 | -0.25 | -0.25 | -0.09 | -0.24 | Upgrade
|
| Interest & Investment Income | 0.57 | 0.66 | 0.02 | - | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | 0 | 0.14 | -0.05 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.02 | 1.27 | 2.68 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -16.23 | -20.45 | -22.77 | -16.41 | -10.74 | -9.82 | Upgrade
|
| Other Unusual Items | - | - | - | -0.5 | - | - | Upgrade
|
| Pretax Income | -16.23 | -20.45 | -22.77 | -16.91 | -10.74 | -9.82 | Upgrade
|
| Income Tax Expense | 0.11 | 0.06 | -0.04 | 0.02 | 0.01 | -0.23 | Upgrade
|
| Net Income | -16.34 | -20.51 | -22.73 | -16.93 | -10.75 | -9.58 | Upgrade
|
| Net Income to Common | -16.34 | -20.51 | -22.73 | -16.93 | -10.75 | -9.58 | Upgrade
|
| Shares Outstanding (Basic) | 32 | 32 | 31 | 15 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 32 | 31 | 15 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 3.62% | 2.23% | 100.28% | 1956.96% | - | - | Upgrade
|
| EPS (Basic) | -0.51 | -0.65 | -0.74 | -1.10 | -14.33 | -12.78 | Upgrade
|
| EPS (Diluted) | -0.51 | -0.65 | -0.74 | -1.10 | -14.33 | -12.78 | Upgrade
|
| Free Cash Flow | -16.5 | -18.62 | -20.8 | -18.08 | -13.35 | - | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -0.59 | -0.67 | -1.17 | -17.80 | - | Upgrade
|
| Gross Margin | - | - | - | - | - | -24.59% | Upgrade
|
| Operating Margin | - | - | - | - | - | -162.36% | Upgrade
|
| Profit Margin | - | - | - | - | - | -162.61% | Upgrade
|
| EBITDA | -15.09 | -19.51 | -21.48 | -16.77 | -13.01 | -3.3 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -56.05% | Upgrade
|
| D&A For EBITDA | 1.52 | 1.38 | 1.05 | 0.81 | 0.27 | 6.26 | Upgrade
|
| EBIT | -16.61 | -20.89 | -22.53 | -17.58 | -13.28 | -9.57 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -162.36% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 6.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.